Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: sylvester80 who wrote (1338819)	1/18/2022 8:28:20 AM
From: Maple MAGA	3 Recommendations Recommended By D.Austin locogringo Mick Mørmøny Respond to of 1572965

"Your boyfriend FJB has the HIGHEST BANS RECEIVED IN SI HISTORY... followed by your twin brother golfer72... so congrats to you trumptards... " You have way more ignores, 113 in fact, 114 after I post... HAHAHAHAHAHAHAHAHAHAHAHAHAHAHA

To: sylvester80 who wrote (1338819)	1/18/2022 9:36:31 AM
From: locogringo	2 Recommendations Recommended By D.Austin Mick Mørmøny Read Replies (1) \| Respond to of 1572965

Here'e some factual reality for you to cry about sylvia... Fourth shot of Covid vaccine is NOT enough to prevent 'lots of infections' from Omicron, Israeli study finds Daily Mail (UK), by Kaya Terry Original Article The fourth dose of the Covid vaccine is less effective on the Omicron variant and provides only limited defence, a preliminary study in Israel has found. Israel's Sheba Medical Center began administering a fourth vaccine to more than 270 medical staff last month during a trial program. Experts studied the defence of the Pfizer booster in 154 people after two weeks and the Moderna booster in 120 people—who had previously been vaccinated three times with the Pfizer vaccine—after one week. The clinical trial found that both groups showed increases in antibodies 'slightly higher' than following the third vaccine last year. But it said the increased antibodies did not prevent the spread of Omicron Lead researcher said: 'For the Omicron variant the vaccine is not good enough' Even a fourth dose of a Covid vaccine isn't enough to stop people getting infected with Omicron, according to the preliminary results of a trial. The study of more than 270 medical staff in Israel found the fourth shot only raised antibodies 'a little' compared to those who were triple-vaccinated. Participants given four doses were only 'a bit less' likely to test positive for the mutant strain than those who had received three. The findings were true for both Pfizer and Moderna, and will reignite the debate about whether constant boosting is necessary.